Autologous bone marrow-derived stem cells for treatment of liver cirrhosis

This study aims to infuse autologous bone marrow-derived stem cells (BM-MSCs) during open abdominal portal hypertension surgery, in order to treat esophageal variceal bleeding and hypersplenism and to improve liver function.